Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history

Eric Jorgenson, Steven R. Deitcher, Mine Cicek, Xin Liu, Sarah Plummer, Graham Casey, John S. Witte

Research output: Contribution to journalArticle

9 Scopus citations

Fingerprint Dive into the research topics of 'Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history'. Together they form a unique fingerprint.

Medicine & Life Sciences